Authors

  • Eshmetova S.I.

Keywords:

chronic kidney disease; maintenance hemodialysis; cardiovascular complications; CYP11B2; T344C polymorphism; genetic susceptibility; left ventricular remodeling; left ventricular mass index; aldosterone; echocardiography.

References

1. Abdel Ghafar M.T. Association of aldosterone synthase CYP11B2 (-344C/T) gene polymorphism with essential hypertension and left ventricular hypertrophy in the Egyptian population // Clinical and Experimental Hypertension. – 2019. – Vol. 41, No. 8. – P. 779–786. – DOI: 10.1080/10641963.2018.1557679.

2. Ahmadmehrabi S., Tang W.H.W. Hemodialysis-induced cardiovascular disease // Seminars in Dialysis. – 2018. – Vol. 31, No. 3. – P. 258–267. – DOI: 10.1111/sdi.12694.

3. Barrera-Chimal J., Bonnard B., Jaisser F. Roles of Mineralocorticoid Receptors in Cardiovascular and Cardiorenal Diseases // Annual Review of Physiology. – 2022. – Vol. 84. – P. 585–610. – DOI: 10.1146/annurev-physiol-060821-013950.

4. Bauersachs J., Lother A. Mineralocorticoid receptor activation and antagonism in cardiovascular disease: cellular and molecular mechanisms // Kidney International Supplements. – 2022. – Vol. 12, No. 1. – P. 19–26. – DOI: 10.1016/j.kisu.2021.11.001.

5. Bauersachs J. [Coauthors require verification]. Mineralocorticoid Receptor in Cardiovascular Diseases—Clinical Trials and Mechanistic Insights // British Journal of Pharmacology. – 2022. – DOI: 10.1111/bph.15708. [Bibliographic details require verification].

6. Charfeddine S., Abid L., Hammami R., Bahloul A., Triki F., Kammoun S. Left ventricular myocardial function in hemodialysis patients: the effects of preload decrease in conventional, Doppler and speckle tracking echocardiography parameters // Pan African Medical Journal. – 2021. – Vol. 38. – Article 45. – DOI: 10.11604/pamj.2021.38.45.9407.

7. Echefu G., Stowe I., Burka S., Basu-Ray I., Kumbala D. Pathophysiological concepts and screening of cardiovascular disease in dialysis patients // Frontiers in Nephrology. – 2023. – Vol. 3. – Article 1198560. – DOI: 10.3389/fneph.2023.1198560.

8. Epstein M., Kovesdy C.P., Clase C.M., Sood M.M., Pecoits-Filho R. Aldosterone, Mineralocorticoid Receptor Activation, and CKD: A Review of Evolving Treatment Paradigms // American Journal of Kidney Diseases. – 2022. – Vol. 80, No. 5. – P. 658–666. – DOI: 10.1053 /j.ajkd.2022.04.016.

9. Io H., Nakata J., Inoshita H., Ishizaka M., Tomino Y., Suzuki Y. Relationship among Left Ventricular Hypertrophy, Cardiovascular Events, and Preferred Blood Pressure Measurement Timing in Hemodialysis Patients // Journal of Clinical Medicine. – 2020. – Vol. 9, No. 11. – Article 3512. – DOI: 10.3390/jcm9113512.

10. Kidney Disease: Improving Global Outcomes (KDIGO) CKD Work Group. KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease // Kidney International. – 2024. – Vol. 105, No. 4S. – P. S117–S314. – DOI: 10.1016/j.kint.2023.10.018.

11. Nguyen N.N., Van Duong P., Ngoc Mai T.H., Vo N.H., Luong D.K., Ngo T.H. Left Ventricular Mass Index in End-Stage Renal Disease Patients during Hemodialysis and Continuous Ambulatory Peritoneal Dialysis // International Journal of Clinical Practice. – 2023. – Vol. 2023. – Article 8816478. – DOI: 10.1155/2023/8816478.

12. Reaves A.C., Weiner D.E., Sarnak M.J. Home Dialysis in Patients with Cardiovascular Diseases // Clinical Journal of the American Society of Nephrology. – 2024. – Vol. 19, No. 12. – P. 1646–1655. – DOI: 10.2215/CJN.0000000000000410.

14. Sharapov O.N., Daminov B.T., Yarygina S.V. Cardiovascular pathologies in the urban population of the Republic of Uzbekistan with chronic kidney disease on hemodialysis // Kidneys. – 2020. – Vol. 9, No. 3. – P. 137–143. – DOI: 10.22141/2307-1257.9.3.2020.211459.

15. Zhang Z., Wang Y. Management of Cardiovascular Diseases in Chronic Hemodialysis Patients // Reviews in Cardiovascular Medicine. – 2023. – Vol. 24, No. 7. – Article 185. – DOI: 10.31083/j.rcm2407185.

16. Zhao X., Zhu L., Jin W., Yang B., Wang Y., Ni M., Zhao Y., Gan L., Zuo L. Echocardiographic left ventricular hypertrophy and geometry in Chinese chronic hemodialysis patients: the prevalence and determinants // BMC Cardiovascular Disorders. – 2022. – Vol. 22. – Article 55. – DOI: 10.1186/s12872-022-02506-y.